143 related articles for article (PubMed ID: 38514271)
21. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
[TBL] [Abstract][Full Text] [Related]
22. Functional long non-coding RNAs in hepatocellular carcinoma.
Xie C; Li SY; Fang JH; Zhu Y; Yang JE
Cancer Lett; 2021 Mar; 500():281-291. PubMed ID: 33129957
[TBL] [Abstract][Full Text] [Related]
23. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Dong H; Jian P; Yu M; Wang L
J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z
BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
26. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
Huang X; Gao Y; Qin J; Lu S
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of Long Non-Coding RNA ENST00000429227.1 Is Correlated with Poor Prognosis in Human Hepatocellular Carcinoma.
Zhao Y; Kong CQ; Ye JZ; Bai T; Luo T; Wang D; Chen M; Wang HF; Wang XB; Liu JJ; Chen J; Luo HL; Li LQ
Med Sci Monit; 2019 Aug; 25():6539-6546. PubMed ID: 31472071
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
Zhou Q; Zhang W; Wang Z; Liu S
BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
[TBL] [Abstract][Full Text] [Related]
30. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
31. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
33. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
34. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA small nucleolar RNA host genes: functions and mechanisms in hepatocellular carcinoma.
Li Y; Wang X; Chen S; Wu B; He Y; Du X; Yang X
Mol Biol Rep; 2022 Mar; 49(3):2455-2464. PubMed ID: 34989961
[TBL] [Abstract][Full Text] [Related]
36. ncRNA-mediated fatty acid metabolism reprogramming in HCC.
Xu K; Xia P; Chen X; Ma W; Yuan Y
Trends Endocrinol Metab; 2023 May; 34(5):278-291. PubMed ID: 36890041
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
Wang YG; Wang T; Shi M; Zhai B
J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
[TBL] [Abstract][Full Text] [Related]
38. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
39. Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma.
Mo M; Ma X; Luo Y; Tan C; Liu B; Tang P; Liao Q; Liu S; Yu H; Huang D; Zeng X; Qiu X
BMC Cancer; 2022 Oct; 22(1):1098. PubMed ID: 36289466
[TBL] [Abstract][Full Text] [Related]
40. LncRNA-ATB promotes autophagy by activating Yes-associated protein and inducing autophagy-related protein 5 expression in hepatocellular carcinoma.
Wang CZ; Yan GX; Dong DS; Xin H; Liu ZY
World J Gastroenterol; 2019 Sep; 25(35):5310-5322. PubMed ID: 31558875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
